Market revenue in 2020 | USD 223.0 million |
Market revenue in 2028 | USD 302.2 million |
Growth rate | 3.9% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.57% in 2024. Horizon Databook has segmented the UAE infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Being a high-income country, the UAE government aims to provide universal access of updated and advanced healthcare services to its citizen by 2021. Due to its vast financial resources and adequate government funding, the diagnostics market in UAE is likely to progress steadily.
Furthermore, the UAE Ministry, in 2018, launched a campaign to eradicate tuberculosis by educating people on the importance of early detection and prevention. In addition, the country has conducted over 75.29 million COVID-19 tests as of September 2021 and has made testing for coronavirus mandatory.
The rate of testing for the infection in the country is the highest in the world with more than 107,000 tests per one million of the population. Furthermore, in April 2020, Group 42 and BGI launched a new laboratory in 14 days with a capacity to perform 10,000 RT-PCR tests per day for COVID-19 in the UAE.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account